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The protozoan parasites Theileria annulata and Theileria parva are unique amongst
intracellular eukaryotic pathogens as they induce a transformation‐like phenotype in
their bovine host cell. T. annulata causes tropical theileriosis, which is frequently fatal,
with infected leukocytes becoming metastatic and forming foci in multiple organs
resulting in destruction of the lymphoid system. Exosomes, a subset of extracellular
vesicles (EV), are critical in metastatic progression in many cancers. Here, we
characterised the cargo of EV from a control bovine lymphosarcoma cell line (BL20)
and BL20 infected with T. annulata (TBL20) by comparative mass spectrometry and
microRNA (miRNA) profiling (data available via ProteomeXchange, identifier
PXD010713 and NCBI GEO, accession number GSE118456, respectively). Ingenuity
pathway analysis that many infection‐associated proteins essential to migration and
extracellular matrix digestion were upregulated in EV fromTBL20 cells compared with
BL20 controls. An altered repertoire of host miRNA, many with known roles in
tumour and/or infection biology, was also observed. Focusing on the tumour suppres-
sor miRNA, bta‐miR‐181a and bta‐miR‐181b, we identified putative messenger RNA
targets and confirmed the interaction of bta‐miR181a with ICAM‐1. We propose that
EV and their miRNA cargo play an important role in the manipulation of the host cell
phenotype and the pathobiology of Theileria infection.1 | INTRODUCTION
The tick‐borne parasites of ruminants Theileria annulata and Theileria
parva are responsible for significant pathology, productivity, and
economic loss over large areas of the old world. T. annulata causes
tropical theileriosis, and is widespread in tropical and subtropical
regions, including parts of Southern Europe, where infection rates
of approximately 30% have been recorded (Gomes et al., 2016). In
North Africa and India, T. annulata is the primary tick‐borne infection
of cattle with an estimated 40 million cattle at risk of infection,- - - - - - - - - - - - - - - - - - - - - - - - - - -
e Creative Commons Attribution Li
ed by John Wiley & Sons Ltdcompromising the livelihood of many small‐scale farmers and costing
the economy an estimated $348 million per annum. In sub‐Saharan
Africa, T. parva is the causative agent of east coast fever, a condition
that is frequently fatal. These Theileria spp are unique amongst
apicomplexan parasites because of their ability to transform host
cells, which, in the case of T. annulata, are myeloid cells, dendritic
cells (DC), and B cells. Following invasion by the sporozoite and
development of the macroschizont stage, the infected host cell
undergoes a phase of uncontrolled proliferation and metastasis,
characteristics with similarities to cancer cells. Previous studies have- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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2 of 13 GILLAN ET AL.shown that the constitutive activation of genes controlled by key
transcription factors, NFkB and AP1, is critical for cellular transforma-
tion (as reviewed in Shiels et al., 2006) and proliferating Theileria‐
infected cells are resistant to apoptosis (Heussler et al., 1999).
Understanding the molecular mechanisms underlying these
events may offer novel avenues for intervention, as current control
of theileriosis is problematic. In some countries, cattle are vaccinated
with T. annulata‐infected cells, attenuated by prolonged in vitro pas-
sage (Ali et al., 2008), but these vaccines carry the continued risk of
reversion to virulence and are difficult to produce and deliver. Conse-
quently, they are not widely deployed in endemic regions. Limiting the
spread of infection is possible using externally applied acaricides
against the vector, but resistance to these chemicals compromises
control (Abbas, Zaman, Colwell, Gilleard, & Iqbal, 2014) and their use
has environmental implications. Theileria infection can be controlled
by chemotherapy, primarily using buparvaquone, but just as with tick
control, drug resistance has been identified (Mhadhbi, Chaouch,
Ajroud, Darghouth, & BenAbderrazak, 2015), and the cost of treat-
ment is relatively high. Thus, to improve productivity in endemic
regions, development of novel treatments and vaccines is required, a
challenge that requires greater understanding of the molecular mech-
anisms involved in parasite manipulation of the host cell. The potential
socio‐economic impact of improved control of T. parva was illustrated
in a recent study of pastoralist households in Kenya. Uptake of a
vaccine was predicted to be positively associated with increased
household income and expenditure on food and had a significant
effect on the likelihood of children attending school (Marsh, Yoder,
Deboch, McElwain, & Palmer, 2016).
In this paper, we adopted a novel approach to understanding the
molecular mechanisms underlying the pathogenesis of T. annulata,
focusing on extracellular vesicles (EV) and their microRNA (miRNA)
cargo. EV have important roles in cell–cell communication and have
beenparticularlywell characterised in cancerbecauseof their role in var-
ious processes leading to oncogenesis, including their capacity to gener-
ate a metastatic niche, which allows the engraftment of tumour cells
elsewhere in the body (Costa‐Silva et al., 2015; Hoshino et al., 2015).
The best‐described subset of EV are exosomes, which derive from the
endocytic pathway, display a characteristic cup‐shaped morphology
and are approximately 50–150 nm in size. Other classes of EV, such as
microvesicles bud from the plasma membrane, while apoptotic bodies
occur when cells are undergoing apoptotic fragmentation. These sub-
typeshavea larger size range (50 to2000nmand50 to5000nm, respec-
tively) and lack the cup‐shape morphology unique to exosomes
(reviewed in Edgar, 2016). Despite these differences, distinguishing
exosomes from other EV is complex, and there is no single reliable
marker for their identification. Consequently, in this manuscript, we
use the terminology EV throughout. EV can contain protein and nucleic
acids, such asmiRNAormessenger RNA (mRNA). Depending on the cell
type from which they are derived, their role in cellular communication
can vary, relating to the complex and dynamic nature of their cargo.
EV are gaining prominence in infectious disease biology, with
several recent studies highlighting their importance in both pathology
and the modulation of host immune responses (reviewed in Robbins
and Morelli, 2014). For example, EV from Trypanosomes have been
implicated in the development of anaemia (Szempruch et al., 2016),while EV from Plasmodium‐infected red blood cells are important in
malaria pathogenesis (Mantel et al., 2016). EV are also involved in
the initiation and/or regulation of immune responses: They can
mediate the transfer of antigenic peptides from infected cells to
antigen‐presenting cells and can deliver either stimulatory or suppres-
sive signals to regulate the induction and differentiation of immune
responses (reviewed in Robbins and Morelli, 2014). Tumour‐derived
EV are most often associated with immune suppression, while EV
from Plasmodium‐infected reticulocytes induce protection via their
interaction with CD4 and CD8 cells (Martin‐Jaular et al., 2016).
Notably, many of the properties of EV are mediated via their miRNA
cargo (Mantel et al., 2016).
Here, we compared the protein and miRNA profile of EV from
T. annulata infected (TBL20) and control uninfected cells (BL20).
Proteomic analysis revealed that a large number of host proteins were
elevated in infected relative to uninfected EV. The expression of
several miRNAs was also shown to be dysregulated in EV from
TBL20 cells (TBL20‐EV) compared with EV from BL20 cells (BL20‐
EV). While each of the differentially expressed miRNA have known
roles in regulating aspects of the immune response or in oncogenesis,
we focus on the tumour suppressor miRNA, bta‐miR‐181a/b and their
interaction with potential target molecules. Our results indicate that
infection‐associated EV proteins and miRNA may play a key role in
the pathobiology of this important veterinary pathogen.2 | RESULTS
2.1 | Identification of EV from BL20 and TBL20 cells
BL20‐EV and TBL20‐EVwere characterised using a variety of methods.
Electron microscopy revealed vesicles of the correct size for exosomes
(~100 nm) in the preparations from both BL20 and TBL20 culture
supernatants using ultracentrifugation (Figure 1a). Western blots
showed that CD63was highly enriched in BL20‐EV and TBL20‐EV sam-
ples and virtually absent in the corresponding whole cell extracts and
EV depleted supernatant. Rab‐5B was present in EV preparations and
cell extracts but absent in EV depleted supernatants. CYC1, amitochon-
drial associated protein, was used as a negative control andwas present
in cell extracts but absent in EV preparations and EV depleted superna-
tants as would be expected (Figure 1b). Quantification by either NTA or
EXOCET yielded 5 × 108 to 1 × 109 EV per million cells. Additionally, to
examine whether TBL20‐EV have the capacity to enter other cells,
PKH‐67 labelled EV were incubated with BL20 cells for 2 hr and exam-
ined using fluorescence microscopy. Figure 1c shows a representative
image demonstrating the presence of labelled EV within the recipient
cells. When EV depleted supernatants were labelled using the same
protocol and included as a negative control, no intracellular particles
were detected (Figure 1d).
2.2 | BL20‐EV and TBL20‐EV exhibit differences in
protein composition/cargo
Proteomic analysis of bothTBL20‐EV and BL20‐EV samples generated
a list of 1,068 quantifiable proteins from Progenesis. These data have
FIGURE 1 EV shed by BL20 and TBL20
cells. (a) Whole mount transmission electron
microscopy of purified exosomes fromTBL20.
Scale bar represents 100 nm. (b) Western blot
analysis of 1. BL20 whole cell extract; 2.
TBL20 whole cell extract; 3. BL‐EV
(ultracentrifugation); 4. TBL‐EV
(ultracentrifugation); 5. BL20 concentrated EV
depleted supernatant; 6. TBL20 concentrated
EV depleted supernatant. Antibodies for
mouse antibovine CD63 (1:500, AbD Serotec),
rabbit antihuman Rab 5B (1:500, Santa Cruz
Biotechnology), and rabbit antibovine Cyc1
(1:1000, Aviva Systems Biology) were used.
Fluorescent microscopy images at ×60
magnification of DAPI stained BL20 cells
incubated with (c) PKH‐67 labelled TBL20‐EV
and (d) EV depleted supernatant from TBL20
cultures. Green, EV (white arrows) and blue,
DAPI stained nuclei. Scale bars represent
10 μm
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(Vizcaino et al., 2016) partner repository with the dataset identifier
PXD010713 and 10.6019/PXD010713. Prior to differential expres-
sion analysis, this list of 1,068 proteins was searched for the top
100 proteins in the Exocarta database of exosome‐associated mole-
cules (http://www.exocarta.org/exosome_markers). Seventy of these
key exosome markers were present in both TBL20‐EV and BL20‐EV
populations, consistent with the isolation of a population of EV highly
enriched with exosomes. Table S2 lists the 100 exosome markers and
gives their normalised abundance in TBL20‐EV and BL20‐EV.
While both populations of EV contained proteins in common, dif-
ferential expression analysis showed a clear divergence between
BL20‐EV and TBL20‐EV, with no outliers at ANOVA p ≤ 0.05 at either
the peptide or protein level (Figure S1 represents PCA biplots of indi-
vidual samples). To increase the confidence of downstream analysis, in
addition to statistical significance (ANOVA p ≤ 0.05), only those pro-
teins identified by two or more unique peptides and exhibiting a foldchange ≥2 were selected, resulting in a total of 479 significantly dif-
ferentially expressed proteins. Of these, 395 were elevated in
TBL20‐EV compared with BL20‐EV, whereas 84 were elevated in
BL20‐EV compared with TBL20‐EV (depicted in Figure 2 and listed
Table S3). Proteins up‐regulated in TBL20‐EV included many previ-
ously identified in TBL20 cells (Kinnaird et al., 2013a) with likely func-
tions in extracellular matrix degradation (e.g., MMP‐9), and several
involved in the immune response (e.g., ICAM‐1 and BOLA‐1). These
results demonstrate that the presence of the parasite alters host pro-
tein expression levels in EV, as well as in host cells. In order to cluster
these proteins into functional networks, the datasets were uploaded
to ingenuity pathway analysis (IPA). Of the 395 proteins elevated in
TBL20‐EV, the most significant biological processes were “infectious
disease” and “cancer.” The pie chart in Figure 3 represents the top five
enrichment terms generated by IPA for up‐regulated proteins in
TBL20‐EV. These pathways are ranked in order of significance as
shown in the table in Figure 3.
FIGURE 2 Volcano plot depicts differences in protein cargo in
TBL20‐EV vs. BL20‐EV. All proteins detected by Progenesis QI were
plotted. Each circle represents one protein. The log2 fold change in the
TBL20‐EV vs. BL20‐EV is represented on the x‐axis. The y‐axis shows
the negative log10 of the ANOVA p value. Different colours of circles
represent proteins with the following: red, ANOVA p > 0.05; purple,
ANOVA p ≤ 0.05; dark green, ANOVA p ≤ 0.05, ≥2 unique peptides
and ≥2 fold change; pale green, ≥2 unique peptides and ≥2 fold
change. ICAM‐1, MMP‐9, and BOLA‐1 are annotated to illustrate their
levels of significance. All proteins above the solid horizontal line are
significantly different between the groups, with ANOVA p ≤ 0.05. The
top left panel contains proteins, which are reduced in TBL20‐EV
compared with BL20‐EV, and the top right panel contains proteins,
which are increased in TBL20‐EV compared with BL20‐EV, only those
in dark green were used in downstream analysis
FIGURE 3 Ingenuity pathway analysis (Qiagen) of EV proteomic
data. Three hundred and ninety‐five proteins significantly
upregulated in TBL20‐EV, as listed in Table S3, were used for these
analyses. The top five molecular and cellular functions and canonical
pathways are shown in the pie chart and table. Threshold criteria
considered for the analysis are ANOVA p ≤ 0.05, ≥2 unique peptides,
and ≥2 fold change
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miRNA cargo
The results of miRNA profiling of BL20‐EV and TBL20‐EV showed that
the expression of 15 miRNA differed significantly between the groups
at p < 0.01, and 39 at p < 0.05 (data available at NCBI GEO, accession
number GSE118456). In order to select miRNA of interest, we applied
a cut‐off of p < 0.01 and a read count of >500, which gave a list of six
miRNA, each of which has known functions in various models of malig-
nancy and/or infectious disease. These results are shown in Figure 4a,
where the heat map depicts the level of differential expression
between samples, and in Table 1, in which log2 fold changes are
detailed. bta‐miR‐222, bta‐miR‐24‐3p, bta‐miR‐27a‐3p, bta‐miR‐155,
and bta‐miR‐146a are all enriched in TBL20‐EV compared with BL20‐
EV, while bta‐miR‐181a and b showed a contrasting profile and are
downregulated in TBL20‐EV compared with BL20‐EV. Each of the
upregulated miRNA are associated with tumours and promote prolifer-
ation (see Table 1), while bta‐miR‐181a/b can act as tumour suppres-
sors (Huang, Ye, Yang, Shi, & Zhao, 2015; Wang et al., 2015; Weng,
Lal, Yang, & Chen, 2015). The differential expression revealed by
RNA‐Seq analysis was confirmed via qRT‐PCR for the six candidate
miRNA on separate biological replicates of BL20‐EV and TBL20‐EV
(Figure 4b). In addition, miRNA qRT‐PCR was carried out on BL20
and TBL20 cells to determine whether specific miRNA might be selec-
tively packaged into EV. However, the cellular expression pattern of all
six miRNA was similar to that observed in EV (Figure 4c). We also
characterised the expression of all six miRNA in a different cell line
infected with Theileria, TBL‐3 compared with its uninfected partner
BL‐3. All miRNA showed a similar pattern of expression in EV isolated
fromTBL‐3 cells relative to BL‐3 cells; in whole cell extracts, only bta‐
miR‐155 was different (Figure S2). In subsequent experiments, we
focused our efforts on defining the function of the tumour suppressor
miRNA, bta‐miR‐181a/b in Theileria infected cells.2.4 | Computational analysis of bta‐miR‐181a and b
mRNA targets
Reduced levels of bta‐miR‐181a and bta‐miR‐181b in TBL20 cells may
result in higher levels of expression of their target mRNA and
increased levels of their protein products in EV. As miRNA bind to par-
tially complementary sequences usually within the 3′ UTR of their tar-
get mRNAs, these targets can be predicted computationally (Rajewsky,
2006; Ritchie & Rasko, 2014). The 3′ UTR of the genes encoding the
top 15 upregulated proteins in TBL20‐EV were analysed for bta‐miR‐
181a and bta‐miR‐181b binding sites. bta‐miR‐181a and bta‐miR‐
181b sequences were downloaded from miRBase release 21 (http://
www.mirbase.org/; Kozomara & Griffiths‐Jones, 2014) and have iden-
tical seed sequences; however, their secondary structure predicted by
folding and hybridisation software Mfold (http://unafold.rna.albany.
edu; Zuker, 2003) is different (Table S4). For this reason, bta‐miR‐
181a and bta‐miR‐181b targets were analysed separately. High confi-
dence potential mRNA targets were defined by a ddG score of <−7
defined by the PITA algorithm and are highlighted in bold (Table 2).
Amongst these were vesicle‐associated proteins TSN‐6 and IST‐1
FIGURE 4 miRNA profile of TBL20‐EV. (a)
Differentially expressed miRNA determined
by RNA‐Seq are depicted in a heat map
p ≤ 0.01. (b) Histograms depicting
comparative qRT‐PCR data from biological
replicates of EV confirms RNA‐Seq data and
(c) cell of origin samples show a similar profile.
Only miRNA with p ≤ 0.01 and a read count
>500 were selected for analysis by qRT‐PCR.
log2 fold change is calculated by comparing
test samples (TBL20‐EV) to calibrator samples
(BL20‐EV) using the constitutively expressed
miRNA bta‐miR‐30e‐3p as an internal
normaliser
TABLE 1 Host miRNA differentially expressed in TBL20‐EV compared with BL20‐EV
microRNA Log2 (p value) Function
bta‐miR‐222 1.63 (p = 1.5E‐05) Oncogene in many human malignancies (Felicetti et al., 2016; Kara et al., 2015;
Li et al., 2016; M. Wang et al., 2016)
bta‐miR‐24‐3p 2.66 (p = 1.5E‐05) Promotes cell proliferation and inhibits apoptosis in human breast cancer (Lu et al., 2015)
bta‐miR‐27a‐3p 3.39 (p = 3.3E‐05) Promotes cellular proliferation (Kara et al., 2015; Nakata et al., 2015; Wu et al., 2015)
bta‐miR‐155 2.94 (p = 9.3E‐04) Tumour associated miRNA (Faraoni, Antonetti, Cardone, & Bonmassar, 2009;
Jurkovicova et al., 2014; Kara et al., 2015)
bta‐miR‐146a 2.76 (p = 4.3E‐05) Tumour associated miRNA (Petrovic, Davidovic, Bajic, Obradovic, &
Isenovic, 2017; Sun et al., 2015)
bta‐miR‐181a/b −1.35/−1.05 (p = 8E‐05/2E‐05) Tumour suppressors (Shi et al., 2008; H. Wang et al., 2015; Weng et al., 2015)
Note. miRNA: micro RNA; TBL20‐EV: extracellular vesicles from Theileria annulata infected line; BL20‐EV: extracellular vesicles from bovine lymphoblastoid
cell line.
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function associated antigen‐1, an interaction that contributes to the
migration of leukocytes across the endothelium (Gahmberg, Tolvanen,
& Kotovuori, 1997; Hogg, Laschinger, Giles, & McDowall, 2003). Pre-
vious studies have shown that ICAM‐1 mRNA is upregulated inTBL20
cells (Durrani, Weir, Pillai, Kinnaird, & Shiels, 2012). Additionally,
matrix metalloproteinase 9 (MMP‐9) was significantly overexpressed
inTBL20‐EV compared with BL20‐EV and shown to be a potential tar-
get of miR‐181a and b. MMP‐9 is upregulated at the “pre‐metastatic
niche” in lung metastasis (Kaplan et al., 2005), and various MMPs have
been shown to be present in tumour cell EV (Dolo et al., 1999;
Hakulinen, Sankkila, Sugiyama, Lehti, & Keski‐Oja, 2008) and to have
a role in metastasis of TBL20 cells (Adamson, Logan, Kinnaird,Langsley, & Hall, 2000). Although significantly altered in TBL20‐EV
(but not in the top 15 differentially expressed proteins), BOLA‐1
(ranked 83) was also included as a possible target of bta‐miR‐181a
and b, due to its role in antigen presentation to CD8+ T cells, a major
effector mechanism of protective immunity against theileriosis (Shaw,
Tilney, Musoke, & Teale, 1995).2.5 | Functional confirmation of bta‐miR‐181a/b
binding to target mRNAs
Three predicted targets of bta‐miR‐181a or b from the bioinformatic
analysis were further investigated by transfection of HEK293 cells in
TABLE 2 The top 15 upregulated proteins in TBL20‐EV compared with BL20‐EV and predicted bta‐miR‐181a and bta‐miR‐181b binding sites
Gene
Fold change
(up in TBL20‐EV) q value
No. of miR‐181a
binding sites
(combined ddG)
No. of miR‐181b
binding sites
(combined ddG)
VTA1_BOVIN Vacuolar protein sorting‐associated proteinb 16.5 3.13E‐08 4(−2.99) 3 (−5.37)
ICAM‐1_BOVIN Intercellular adhesion molecule 1 9.6 4.96E‐08 2 (−9.01) 0
NEUM_BOVIN Neuromodulin 56.2 7.06E‐08 1 (2.51) 1 (−4.86)
TSN6_BOVIN Tetraspanin‐6b 12.6 8.72E‐08 1 (−6) 1 (−9)
VPS4B_BOVIN Vacuolar protein sorting‐associated protein 4Bb 9.5 8.72E‐08 2 (−4.88) 2 (−6.32)
MFGM_BOVIN Lactadherin 6.6 8.72E‐08 0 0
SATT_BOVIN Neutral amino acid transporter A 7.3 1.85E‐07 0 1 (−6)
ITA5_BOVIN Integrin alpha‐5 6.1 2.02E‐07 0 1 (0.7)
IST1_BOVIN IST1 homologueb 10.5 2.58E‐07 1 (2) 3 (−9)
TMEDA_BOVIN Transmembrane emp24 domain‐containing protein 10b 5.4 2.58E‐07 3 (−4.51) 3 (−4.1)
VPS28_BOVIN Vacuolar protein sorting‐associated protein 28 homologueb 6.8 2.91E‐07 3 (−4.13) 1 (0.51)
CHM1B_BOVIN Charged multivesicular body protein 1bb 9 3.00E‐07 2 (0.2) 3 (5.58)
MMP‐9_BOVIN Matrix metalloproteinase‐9 23.3 9.12E‐07 1 (−13.05) 1 (−11.84)
VAPA_BOVIN Vesicle‐associated membrane protein‐associated protein Ab 10.4 9.12E‐07 2 (−4.76) 2 (−5.83)
MPP7_BOVIN MAGUK p55 Subfamily Member 7 7.5 9.12E‐07 4 (−5.69) 2 (−8.05)
aHA1A_BOVIN BOLA‐1 Class I histocompatibility antigen, alpha chain 3.8 8.47E‐06 2 (−11.95) 2 (−14.5)
Note. TBL20‐EV: extracellular vesicles from Theileria annulata infected line; BL20‐EV: extracellular vesicles from bovine lymphoblastoid cell line.
aBOLA‐1 also included.
bknown components of EV.
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AND BOLA‐1 3′ UTRs were cloned fromTBL20 genomic DNA down-
stream of firefly luciferase and transiently transfected into HEK293
cells along with a plasmid containing bta‐miR‐181a or b in the forward
or reverse direction. ICAM‐1 and BOLA‐1 3′ UTR sequence both
contained two putative bta‐miR‐181a binding sites within their 3′
UTR, while MMP‐9 3′ UTR contained a single site. For bta‐miR‐
181b, the BOLA‐1 3′ UTR contained two binding sites, MMP‐9 3′
UTR contained one, and ICAM‐1 3′ UTR had no predicted binding
sites (see Table 2). Levels of luciferase in the presence of the forward
or reverse bta‐miR‐181a or b were compared. bta‐miR‐181a sup-
pressed the expression of ICAM‐1 3′ UTR fused to luciferase by
66% (p = 0.00095), while no difference was observed for MMP‐9 or
BOLA‐1 3′ UTR (Figure 5a). For bta‐miR‐181b, the suppression of
both ICAM‐1 and MMP‐9 constructs was more moderate, 21% and
7%, respectively, but these results were also significant (p = 0.047FIGURE 5 bta‐miR‐181a interacts with predicted target gene 3′ UTR. Hi
comparing Firefly to Renilla luciferase signal in the presence of bta‐miR‐181
ICAM‐1, MMP‐9, and BOLA‐1. bta‐miR‐181a or bta‐miR‐181b were clone
signal was calculated by comparison of the two (*p ≤ 0.05)and 0.021, respectively, Figure 5b). Transfection of both bta‐miR‐
181a and b together did not enhance the reduction in luciferase (data
not shown). Unexpectedly, a small, but significant increase in BOLA‐1
expression was observed in the presence of bta‐miR‐181a or b
(p = 0.0003 and 0.0185, respectively).2.6 | Overexpression of miR‐181a reduces ICAM‐1
mRNA expression in TBL20 cells
Along with elevated protein expression, mRNA encoding ICAM‐1,
MMP‐9, and BOLA‐1 expression levels were increased in TBL20 cells
compared with BL20 cells (Figure S3). Therefore, it was of interest
to determine if there was a correlation between levels of bta‐miR‐
181a or bta‐miR‐181b and their target genes in infected cells. To this
end, synthetic mimics of miR‐181a and b or a negative transfectionstograms show the mean of three experiments +/− standard deviation
a (a) or bta‐miR‐181b (b) and the 3′ UTRs of predicted targets mRNAs,
d in the forward orientation and reverse orientation, and reduction in
GILLAN ET AL. 7 of 13control cel‐miR‐67 (miRIDIAN Mimic Negative Control #1) were intro-
duced to TBL20 cells by nucleofection. Following transfection of
TBL20 cells, bta‐miR‐181a and b mimics, were detected by qRT‐PCR
while the cel‐miR‐67 control showed no effect on levels of mir‐181a
or b (Figure S4). qRT‐PCR was also carried out to determine if levels
of ICAM‐1, MMP‐9, or BOLA‐1 mRNA were inhibited by the mimics.
Interestingly, ICAM‐1 was significantly downregulated only in the
presence of bta‐miR‐181a (Figure 6a), validating the results from
the dual luciferase assay where bta‐miR‐181a had a much more
pronounced effect on ICAM‐1 than bta‐miR‐181b. Expression of
MMP‐9 and BOLA‐1 mRNA were unaffected by the presence of
bta‐miR‐181a and b mimics (data not shown); therefore, these mRNAs
are unlikely to be true targets of miR‐181a/b in his system.2.7 | Transfection of TBL20 cells with miR‐181a
causes a significant growth phenotype
When BL20 and TBL20 cells were transfected with miR‐181a, b, or
both mimics, we observed a significant reduction in growth of
TBL20 cells in the presence of miR‐181a compared with cells
transfected with cel‐miR‐67. This effect was not observed usingFIGURE 6 Overexpression of miR‐181a
negatively regulates ICAM‐1 mRNA. (a)
Comparative qRT‐PCR results show
significantly reduced levels of ICAM‐1
expression in TBL20 cells when they are
transfected with miR‐181a mimic
(Dharmacon; *p ≤ 0.05). These results were
calibrated against ICAM‐1 expression inTBL20
cells transfected with cel‐miR‐67 negative
control (Dharmacon). bta‐miR‐30e‐3p was
used as an internal normaliser. These results
were not replicated when TBL20 cells were
transfected with miR‐181b mimic. (b)
Schematic representation of ICAM‐1 cDNA
and 3′ UTR showing the conserved miR‐181a
seed region in the 3′ UTR. Bovine miR‐181a
mature sequence with proposed base pairing
to the 3′ UTR are presented. The reverse
complement of bta‐miR‐181 was used as a
control for luciferase assays. Tables show data
from generated using https://genie.weizmann.
ac.il/pubs/mir07/mir07_prediction.html
online prediction tool resulting in a combined
ddG score for ICAM‐1 3’ UTR predicted
binding to bta‐mir‐181a.miR‐181b, and simultaneous transfection of both miR‐181a and b
showed no additive effect (Figure 7). Significantly, this growth pheno-
type was only observed in TBL20 cells and not in BL20 cells. To fur-
ther understand a possible role for miR‐181a in this system, IPA was
used to generate a list of predicted bta‐miR‐181a gene targets.
Selecting only moderate and high confidence predictions, 858 poten-
tial target genes were used in pathway analysis, and the top four
canonical pathways were ceramide degradation, PTEN signalling, T‐
cell signalling, and regulation of IL‐2 expression, all of which are asso-
ciated with cellular proliferation, growth, or apoptosis (Table S5). It is
interesting to note that an alpha subunit of casein kinase II
(CSNK2A2) is a potential target of miR‐181a while other alpha and
beta subunits of casein kinase II (CSNK2A1/CSNK2B) are upregulated
in TBL20‐EV. A previous study has identified this molecule as intrinsic
to Theileria induced lymphocyte transformation (Dessauge, Lizundia, &
Langsley, 2005). Additionally, the list of 858 miR‐181a potential tar-
get genes was cross‐referenced with previous BL20 vs. TBL20 micro-
array data from this lab (Kinnaird et al., 2013b). One thousand five
hundred and ninety‐six genes, which were upregulated in TBL20 cells
versus BL20 cells with an FDR (q value) < 0.05 from that study were
included in the cross referencing. Forty‐four genes were present in
both lists (as shown in Table S6), some of which have roles in the
FIGURE 7 miR‐181a overexpression affects cell number in TBL20
cultures. Graph shows the mean of three experiments where cell
counts fromTBL20 cells transfected with cel‐miR‐67, miR‐181a mimic,
miR‐181b mimic, or both mimics were taken at 24 hr. Counts from
wells containing TBL20 cells expressing miR‐181a mimic or both
mimics consistently and significantly showed decreased numbers
(*p ≤ 0.05)
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Further studies will be required to confirm an association between
miR‐181a and any of these potential targets.3 | DISCUSSION
The transforming species of Theileria are amongst the most intriguing
of eukaryotic pathogens because of their unique ability to subvert
host gene expression, and cause a cancer‐like phenotype in the
infected host leukocyte. Most previous studies have focused on the
association between the parasite and the constitutive activation of
host transcription factors such as NFkB, AP1, and cMyc (Baumgartner
et al., 2000; Dessauge et al., 2005). Here, we describe a potential role
for EV and their cargo in the pathobiology of T. annulata infection. EV
are known to mediate communication between various cell types by
transmitting signals from donor to recipient cells, negating the require-
ment for cell‐to‐cell contact (Tkach & Thery, 2016). The subsequent
reprogramming of recipient cells has provided important insights into
disease progression, most notably in the process of oncogenesis (Choi
et al., 2017). In our experiments, we isolated a population of vesicles
enriched with exosomes from BL20 and TBL20 cells, as judged by
their protein composition, high levels of expression of marker proteins
and size profile. By labelling with PKH67, TBL20‐EV were shown to
enter uninfected cells, demonstrating a potential means of delivering
their content. These observations are particularly pertinent given the
pathogenesis of T. annulata infection, where uncontrolled prolifera-
tion, metastasis, and destruction of the lymphoid system are hallmarks
of acute disease. Although EV can contain a range of components
including mRNA, miRNA, and lipids (Yanez‐Mo et al., 2015), we
focused on the miRNA fraction because of their potential to modulatetarget gene expression. Furthermore, previous studies had implicated
bta‐miR‐155 in the proliferative phenotype of T. annulata cells, by
acting in a positive feedback loop, which results in stabilisation of
c‐Jun and increased transcription of the gene containing bta‐miR‐
155 (Marsolier et al., 2013).
By applying stringent criteria, six miRNA were shown to be
differentially expressed in TBL20‐EV compared with BL20‐EV. These
expression patterns were conserved in TBL20 versus BL20 cells,
indicating that in this case, the EV cargo largely reflects that of the
host cell. A recent publication (Haidar et al., 2018) described the
miRNA of TBL20 and TBL3 cells relative to uninfected cells.
In general, comparison of those data with the EV miRNA
profiles reported here are very similar although there are subtle
differences, possibly reflecting variable culture conditions used in
the different laboratories.
Each of the differentially expressed miRNA identified in our study
has known functions in either infectious disease or cancer. While most
of the miRNA identified function to promote cell proliferation or act as
oncogenes, we focused on two miRNA, bta‐miR‐181a and b, that act
as tumour suppressors (Shi et al., 2008) and that were significantly
downregulated in TBL20‐EV compared with BL20‐EV. In order to
investigate the function of bta‐miR‐181a and b inTBL20 cells, putative
target genes were determined using a dual approach: First, we
selected proteins significantly upregulated in TBL20‐EV versus BL20‐
EV and second, identified those containing binding sites for bta‐miR‐
18a or b within the 3′ UTR of the corresponding mRNA. The
interaction of some of these targets with bta‐miR‐181a/b was then
studied in a dual luciferase assay.
bta‐miR‐181 a and b are closely linked on Chr XVI in an intergenic
region of the bovine genome, and while the closest gene to the bta‐
miR‐181 locus is a protein tyrosine phosphatase receptor type C
(CD45), there is no evidence of any interaction between the miRNA
and this gene (data not shown). Despite sharing identical seed
sequences and highly conserved mature sequences, differences were
observed in the ability of bta‐miR‐181a and bta‐miR‐181b to bind to
ICAM‐1 3’ UTR, with bta‐miR‐181a showing a three‐fold greater
suppressive effect than bta‐miR‐181b. The miR‐181 family has a
well‐characterised role in modulating expression of multiple immune‐
related molecules (Sun, Sit, & Feinberg, 2014) and endothelial‐
expressed molecules such as VCAM (Liu et al., 2017). However, the
major target of bta‐miR‐181a confirmed in this study was ICAM‐1,
which encodes a cell surface glycoprotein expressed on a range of
immune and endothelial cell types. ICAM‐1 is known to be signifi-
cantly overexpressed in TBL20 cells (Kinnaird et al., 2013b) and in
TBL20‐EV as reported here. By analogy with human cancer cells, over-
expression of ICAM‐1 may play a role in metastasis (Yu, Lin, & Tang,
2013). As the dual luciferase assays were carried out in a heterologous
transfection system, we next tested whether overexpression of either
miRNA in TBL20 cells would affect target gene expression and thus
indicate that the mimic was able to enter the miRNA pathway. Over-
expression of bta‐mir‐181a in TBL20 cells resulted in the downregula-
tion of ICAM‐1, while bta‐mir‐181b had no effect on its own. MMP‐9
was also experimentally confirmed as a weak target of bta‐miR‐181b
but not of bta‐miR‐181a in the dual luciferase assay. However, expres-
sion of the miR‐181b mimic in TBL20 cells had no effect on MMP‐9
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unlikely to be a true target of miR‐181b. However, the study of Haidar
et al., demonstrated that a different miRNA, bta‐miR126‐5p, regulates
MMP‐9 expression; transfection of TBL20 cells with an inhibitor of a
bta‐miR126‐5p decreased MMP‐9 levels and reduced the capacity of
the cells to migrate, while transfection with a mimic increased cell
migration (Haidar et al., 2018).
TBL20 cells transfected with miR‐181a or b mimics were also
examined to determine if there were phenotypic alterations that cor-
related with expression of either mimic. We observed that TBL20 cells
proliferated much less well in the presence of miR‐181a mimic while
miR‐181b alone had no such effect. Elevating miR‐181a suppressed
proliferation and cellular growth, but only in the infected cell, consis-
tent with the role of miR‐181a as a tumour suppressor (Shi et al.,
2008). As the mechanism/s underlying the suppression of proliferation
seemed unlikely to involve regulation of ICAM‐1, IPA was performed
on all 858 predicted bta‐mir‐181a mRNA targets. A large number of
potential pathways were highlighted, but the four most significant
were ceramide degradation and PTEN, TGF‐b, and IL‐2 signalling
(Table S5). Each of these pathways is associated with the control of
proliferation and contain genes that may regulate proliferation of
TBL20 cells. Cross‐referencing this list of predicted targets with previ-
ously published microarray data of genes upregulated in TBL20 cells
revealed a list of 44 genes, some of which are involved in cellular pro-
liferation. Future studies will focus on generating experimental data to
examine the specific role played by bta‐miR‐181a in cell proliferation
by confirming some of these interactions.
In conclusion, the miRNA profile of EV and TBL20 cells predicts
their hyper‐proliferative capacity with reduction of major tumour
suppressing miRNA and elevation of pro‐oncogenic miRNA. How
infected cell EV impact on the pathobiology of tropical theileriosis is
yet to be resolved, but it is intriguing to note that in older studies,
parasite infected cells were shown to induce inappropriate activation
and proliferation of naïve T‐cells via a contact and soluble factor
dependent mechanism (Campbel & Spooner, 1999; Campbell, Howie,
Odling, & Glass, 1995). While this phenomenon is likely to be complex,
the role of EV with their altered expression of protein and miRNA,
their ability to enter cells and to mediate immune responses (Robbins
& Morelli, 2014) could have a profound effect on the progression of
T. annulata infection.4 | Experimental procedures
4.1 | Cell culture
BL20 is an immortalised bovine lymphosarcoma cell line (Morzaria,
Roeder, Roberts, Chasey, & Drew, 1982), while TBL20, is a
parasite‐infected cell line obtained by in vitro infection of BL20 cells
with sporozoites of T. annulata (strain Hissar; Shiels, McDougall, Tait,
& Brown, 1986). These two cell lines provide an in vitro system in
which infected and non‐infected cells represent identical bovine
genotypes. Cells were routinely maintained in culture at 37°C in
RPMI with 20% foetal calf serum (FCS) as described previously
(Shiels et al., 1992).4.2 | Isolation and purification of EV
Cells for EV isolation were counted, washed three times in
supplement‐free RPMI, resuspended at 1 × 106 cells/ml in RPMI plus
20% EV depleted FCS (Stratech), and incubated at 37°C for 12 hr prior
to EV preparation. EV were initially isolated from culture supernatants
of BL20 control or TBL20 infected cells by ultracentrifugation as pre-
viously described (Thery, Amigorena, Raposo, & Clayton, 2006).
Briefly, 100 ml of culture was centrifuged at 300× g for 10 min,
2,000× g for 10 min, and 10,000× g for 30 min, with cells and cell
debris discarded at each stage. EV were then pelleted by ultracentrifu-
gation using a Surespin 630 rotor (Sorvall) at 100,000× g for 70 min,
washed in sterile PBS, and finally centrifuged at 100,000× g for
70 min before resuspending in 100 μl of PBS. EV were used immedi-
ately to maximise integrity. When EV were used in cell uptake assays,
they were prepared using exoEasy Maxi Kits (Qiagen) to maintain
sterility. Postelution from exoEasy columns, EV were concentrated
by reducing the volume of elution buffer to 50 μl using Vivaspin 500
centrifugal concentrators (Sartorius).
4.3 | Visualisation and quantification of EV
EV purified from BL20 and TBL20 cells were resuspended in 2%
paraformaldehyde (PFA) and visualised by transmission electron
microscopy (TEM; Thery et al., 2006). EV were also visualised and
quantified, and their size distribution measured using nanoparticle
tracking analysis (NTA) on a NanoSight LM10 with NTA2.3 software
(NanoSight Ltd., Minton Park, United Kingdom). EV were tracked
and sized using Brownian motion. EV samples for NTA were diluted
1:250 in filtered PBS, which was also used as a negative control. The
detection threshold was similar in all samples. NTA quantification of
EV was confirmed using the EXOCET exosome quantitation kit read
at OD405 (Systembio). EXOCET is an enzymatic, colorimetric assay
that directly measures of acetylcholinesterase activity, known to be
enriched, within exosomes (Gupta & Knowlton, 2007; Savina, Vidal,
& Colombo, 2002).
4.4 | Western blotting
EV were isolated from culture supernatants as described above, while
cell extracts were prepared following standard protocols (Kinnaird
et al., 2013a). All proteins were resolved by denaturing SDS‐PAGE
(Laemmli, 1970) except when blotting with anti‐CD63 antibodies,
where extracts were analysed under non‐reducing conditions (no β‐
mercaptoethanol added to sample buffer and no heating to 95°C).
Proteins were visualised by Coomassie blue staining of gels or by
western blotting, carried out by transfer onto PVDF membrane
(Amersham). Blots were probed using the following primary antibod-
ies; mouse monoclonal antibovine CD63 (catalogue no. MCA2042,
dilution, 1/500, BioRad), rabbit polyclonal antihuman Rab‐5B
(catalogue no. sc‐598, dilution, 1/500, Santa Cruz Biotechnology)
and rabbit antibovine Cyc1 (polyclonal, 1/1000, Aviva Systems
Biology). HRP‐conjugated secondary antibodies were routinely used
at one in 10,000 dilution and binding detected using the Enhanced
Chemiluminscent (ECL) system (GE Healthcare).
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TBL20‐EV were labelled with PKH67 Fluorescent Cell Linker Kit
(Sigma), according to the manufacturer's guidelines. Briefly, EV were
incubated with 2 × 10−6 M PKH67 in Diluent C, supplied with the
kit, for 3 min at room temperature. Neat EV‐free FCS was used as a
stop solution and was added in equal volume to the reaction. A nega-
tive control sample containing EV depleted supernatant from TBL20
was also labelled at the same time. BL20 cells at 5 × 105 in 1 ml of
FCS‐free RPMI were incubated with 50 μl of PKH67 labelled
TBL20‐EV or TBL20‐EV depleted supernatant for 2 hr at 37°C. After
incubation, cells were washed three times and resuspended in 1 ml
FCS‐free RPMI and 40 μl of each suspension was analysed by
cytospin, fixed in methanol for 30 min and incubated in 0.04% Evan's
blue solution. After washing in PBS, slides were air dried at room tem-
perature and mounted with ProLong Gold antifade with DAPI (molec-
ular probes), viewed by florescence microscopy on an Olympus BX60
and images captured and overlayed using SPOT advance software.
4.6 | Proteomic sample preparation and LC–MS
analysis
Six biological replicates were used for proteomic analysis of BL20‐EV
and TBL20‐EV. EV pellets were digested and acidified as described
previously (Clarke et al., 2017), and the completeness of digestion
was verified by SDS‐PAGE analysis of the digest preacidification and
postacidification. LC–MS analysis was conducted on a QExactive HF
quadrupole‐Orbitrap mass spectrometer coupled to a Dionex Ultimate
3000 RSLC nano‐liquid chromatograph (Hemel Hempstead, United
Kingdom) described in (Clarke et al., 2017). Label‐free protein quanti-
fication was performed using Progenesis QI for Proteomics v.2.0
(Waters Ltd., Newcastle‐upon‐Tyne, United Kingdom). Raw data files
were imported into Progenesis for peak detection and alignment and
grouped into control BL20‐EV and TBL20‐EV experimental groups.
Data were searched against the UniProt bovine reviewed database
using Mascot v.2.4.1 (Matrix Science, London, United Kingdom). The
false discovery rate at the peptide‐level was set to 1%, and peptide
identifications were further filtered using a peptide ion score of 15
or greater (score indicating identity or extensive homology). Protein
quantification was based on averaging the individual abundances for
every unique peptide for each protein and comparing the relative
abundance across sample runs and between experimental groups.
IPA was applied to proteomic data for functional clustering of proteins
into defined networks.
4.7 | miRNA profiling by RNA‐Seq
RNA was prepared from triplicate samples of BL20‐EV and TBL20‐EV
using Trizol (Thermo Fisher) according to manufacturer's guidelines.
Library preparations and miRNA sequencing, using the Illumina next‐
generation sequencing platform along with downstream statistical
testing and cluster analysis, was carried out by LC Sciences (Houston,
TX, U.S.A.). Cut‐offs of ANOVA p < 0.01 and a read count of >500
were applied to the data. miRNA qRT‐PCR was used to confirm the
profile of miRNA in BL20 and TBL20 cells and EV. Three controlmiRNA, which were found by miRNA‐Seq to be present at similar
levels between experimental conditions, were tested for consistency
between groups, and bta‐miR‐30e‐3p was selected as the normaliser
gene for all subsequent experiments. Triplicate biological replicates
were used throughout and each individual PCR run in triplicate. All
primer sequences are outlined in Table S1.4.8 | Identifying miRNA targets and confirming
miRNA–mRNA interactions in HEK293 cells
3′ UTRs of the genes encoding the top 15 overexpressed proteins in
TBL20‐EVwere identified usingNCBIGENE andUTRdatabasewebsite
(http://utrdb.ba.itb.cnr.it/). As a reduction in bta‐miR‐181a and bta‐miR‐
181b in infected cells may result in an increase in target proteins in EV,
the 3′ UTR of these 15 genes were analysed for potential bta‐miR‐
181a and bta‐miR‐181b binding sites using the online prediction tool
(https://genie.weizmann.ac.il/pubs/mir07/mir07_prediction.html). The
PITA algorithm (Kertesz, Iovino, Unnerstall, Gaul, & Segal, 2007) used
aminimumseed size of eight, allowing for a singleG:Uwobble, and a sin-
gle mismatch and results were refined by considering only those with
PITA ΔΔG energies of <−7. The 3′ UTRs from predicted bta‐mir‐181a
and bta‐mir‐181b target genes encoding BOLA class 1 (bovine MHC
class 1), ICAM‐1, and MMP‐9 were amplified from TBL20 genomic
DNA, using PfuUltra II Fusion HS DNA Polymerase (Agilent). These
genes were selected based upon their potential importance in the path-
ogenesis of Theileria infection and relevance to disease progression.
Primer sequences are shown inTable S1 (restriction sites underlined).
All 3′ UTR PCR products were cloned into pCR2.1‐TOPO
(Invitrogen), and then subcloned into the NotI site downstream of
firefly luciferase in pMir‐Target (Origene). A 387 BP section of the
bta‐miR‐181a locus and a 302 BP region of the bta‐miR‐181b were
amplified from BL20 genomic DNA, cloned into pCR2.1‐TOPO, and
subcloned into vector pEGFP‐N1 (Clontech) using KpnI to generate
plasmids in the forward and reverse orientation.
HEK293 cells were maintained as described previously (Winter
et al., 2015). For transfections, 1 × 104 cells/ml were seeded into
the wells of 96‐well plates in a volume of 100 μl using Dulbecco's
Modified Eagle's Medium (Sigma D5671). After 24 hr, when cells were
approximately 50% confluent, they were transfected using Lipofecta-
mine LTX (Invitrogen) with 50 ng of bta‐miR‐181a or bta‐miR‐
181b‐containing plasmid in either the forward or reverse direction,
25 ng of the relevant pMir‐Target‐derived plasmid, and 0.5 ng of
phRG‐TK (Renilla luciferase, Promega). In experiments where bta‐
miR‐181a and bta‐miR‐181b were cotransfected, 40 ng of each
plasmid was used. Transfections were performed following the manu-
facturer's protocol for HEK293 cells. DNA was diluted to a volume of
20 μl using Opti‐MEM I Reduced Serum Medium (Invitrogen) and
0.35 μl Lipofectamine LTX Reagent added. After incubation at room
temperature for 30 min, 20 μl of the DNA‐Lipofectamine complex
was then added directly to the cells in each well. Cells were grown
for 48 hr, then analysed using a Dual Luciferase Assay kit (Promega)
following the manufactures protocol with six replicates used per test
condition. Results are presented relative to the reverse orientation
control miRNA, where this control is designated a value of 1.
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To obtain transient overexpression of bta‐miR‐181a or b in TBL20
cells, two exogenous miRNA mimics and the miRIDIAN microRNA
mimic transfection control, a Dy547‐labelled microRNA mimic based
on the Caenorhabditis elegans miRNA cel‐miR‐67 (miRIDIAN Mimic
Negative Control #1; Dharmacon) were transfected into TBL20 cells
at 60 nM using an Amaxa Nucleofector (Lonza). This control was used
as it is confirmed to have minimal sequence identity with miRNAs in
human, mouse, and rat. It has identical design and modifications to
miRIDIAN microRNA Mimics and has no identifiable effects on tested
miRNA function (https://dharmacon.horizondiscovery.com/rnai/con-
trols/microrna‐mimic/miridian‐microrna‐mimic‐negative‐control‐1/).
Cells were incubated at 37°C for 48 hr and mRNA isolated using
Trizol reagent. Comparative quantification of ICAM‐1, BOLA‐1, and
MMP‐9 transcripts in TBL20 cells transfected with miR‐181a/b mimic
or the negative control mimic was carried out by qRT‐PCR. gapdh was
used as a normalising gene for all mRNA qRT‐PCR (Durrani et al.,
2012), and all experimentswere carried out in triplicate. In addition, trip-
licate cell cultureswere counted after transfectionwithmimics and con-
trols using standard Trypan blue methods and a haemocytometer.
Predicted putative mRNA targets of miR‐181a were generated and
pathway analysis on this list of genes was carried out using IPA. Eight
hundred and fifty‐eight high andmoderate confidence predictions were
included in this analysis. This list of genes was cross referenced with
previous TBL20 vs. BL20 microarray data from this lab. A cut‐off of
FDR (q‐value) <0.05 was applied to this data resulting in a list of 1,596
genes upregulated inTBL20 cells (Kinnaird et al., 2013b).
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